Endometriosis could be diagnosed via blood test, UK study finds

A groundbreaking study from the University of Edinburgh offers hope for a simpler diagnosis of endometriosis, a painful condition affecting millions of women worldwide. Researchers believe a new blood test, capable of detecting specific hormone differences, could revolutionize how the disease is identified and treated.

The study focused on hormone levels in 159 women diagnosed with endometriosis and 57 without the condition. "These findings mark a significant breakthrough in our understanding of endometriosis," said Dr. Douglas Gibson, the lead researcher. "Traditionally seen as an oestrogen-driven disorder, our research challenges this view by showing different androgen levels in the condition. We are optimistic that this new insight will lead to earlier diagnosis and the development of innovative new treatments for those affected by endometriosis."

Scientists identified a greater presence of a group of androgens, often referred to as "male hormones," in women with endometriosis. This led to the discovery of a distinct "hormone fingerprint" that allowed researchers to differentiate between those with and without the condition. The test proved highly accurate, correctly identifying more than 95 percent of endometriosis patients in the study.

Endometriosis affects an estimated 10 percent of reproductive-age women globally, yet diagnosis often takes seven to 10 years due to a lack of awareness and the normalization of menstrual pain. Current diagnostic methods typically involve invasive laparoscopic surgery. The study's findings not only offer a potential route for earlier diagnosis but also provide crucial insights into the role of androgens in endometriosis development, potentially paving the way for new therapeutic targets.

“

These findings mark a significant breakthrough in our understanding of endometriosis. Traditionally seen as an oestrogen-driven disorder, our research challenges this view by showing different androgen levels in the condition. We are optimistic that this new insight will lead to earlier diagnosis and the development of innovative new treatments for those affected by endometriosis.